Health Business Blog

Health care business consultant and policy expert David E. Williams share his views

Russia rushes its COVID-19 vaccine. Why all is not what it seems

honor guard 67636 1280
Any volunteers?

Russia –yes the Russia that exerts special influence on our president– has done a poor job of keeping the COVID-19 virus in check. But now they claim to have a safe and effective vaccine that’s ready to go.

I’m quoted in the International Business Times (Questions Surround Russia’s Ability to Deliver a Safe, Effective Coronavirus Vaccine)

Some suggest that the vaccine may not be safe – or effective.

“It’s obvious that the Russians are rushing the vaccine to market without adequate testing,” David Eugene Williams, president at Health Business Group, told International Business Times in an email. “It’s possible that the vaccine will work, but there hasn’t been enough time to verify that it’s both safe and effective. The Russians haven’t released any data that would support their claims.”

“I don’t think people will travel to Russia to receive the vaccine because, 1) they won’t trust that it will work, 2) they could get COVID-19 on their travels to Russia, and 3) the Russians may allocate it to their own citizens,” he said.

It would be great if the Russian vaccine works. But we’ll have to wait and see –which is something the developers haven’t done.


By healthcare business consultant David E. Williams, president of Health Business Group.

Telehealth, visualization and the pandemic

art.papier
Dr. Art Papier, VisualDx CEO

Infectious disease expert and dermatologist Art Papier is CEO of VisualDx. In this podcast interview we discuss the pandemic, telehealth, and racial disparities.

Here’s what we covered:

(0:13) Comparing today’s crisis with 9/11 and anthrax attacks
(2:06) Lack of preparation for COVID-19
(3:43) The all hazard approach to bio-preparedness
(7:04) Why COVID-19 hit the US so hard
(8:19) How the pandemic will end
(10:04) Role of virtualization in diagnosis
(13:50) What changes with telehealth
(15:58) Future potential of telehealth
(18:45) Impact of telehealth on equity and disparities
(21:08) What the future holds

—–

Interview conducted by healthcare business consultant David E. Williams, president of Health Business Group. Podcast production by Marina Zapesochny, social media intern.

Can pro sports beat the pandemic?

 

The sudden shutdown of pro sports in March was a shock to the system that made COVID-19 real to the public at large. Wouldn’t it be nice if the restart signaled the end of the pandemic? Alas, it’s instead become a reminder of just how serious a mess we are in.

In this episode of #CareTalk, John Driscoll and I discuss

(0:12) Can any professional sport safely continue operations during the pandemic?
(1:16) The MLB’s “Fish problem”
(3:20) Can Canada do it better? (6:00)
What about the NFL? (8:43)
Where is the USA in the battle against COVID-19?

What do patients think of virtual care? Interview with Kyruus’s Dr. Erin Jospe

Erin Jospe headshot
Dr. Erin Jospe, Kyruus CMO

Patients have been receiving a megadose of virtual care since March. How’s it going and what will it mean long-term? Provider search and scheduling company, Kyruus asked 1000 patients for their opinions and published the findings.

How Patients Learned About Virtual Care Options
How Patients Learned About Virtual Care Options

Kyruus Chief Medical Officer, Dr. Erin Jospe and I had a chance to catch up on the report and speculate about its implications in this podcast.

Here’s what we discussed:

  • (0:15) Key findings and surprises
  • (1:54) Baby Boomers’ affinity for virtual care
  • (3:40) Paradox that Baby Boomers are big utilizers of virtual care but not so likely to switch doctors to get it
  • (6:21) Downsides and limitations of virtual care
  • (10:55) Impact of virtual care on disparities
  • (13:47) Potential to launch a virtual-first practice
  • (17:31) Why Kyruus cares about these results

—-

Interview conducted by healthcare business consultant David E. Williams, president of Health Business Group. Podcast production by Marina Zapesochny, social media intern.

When will COVID-19 vaccine become available?

Operation Warp Speed promises a vaccine in no time (or at least before the election). Is that a pipe dream? And when the vaccine does arrive, how well will it work? How will it be priced? Who will get it? And what will the impact be on the rest of the drug and vaccine market?

John Driscoll and I argue it out in the latest edition of #CareTalk.


—-

 

By healthcare business consultant David E. Williams, president of Health Business Group.